The company
Adlai Nortye Group Ltd. - American Depositary Shares
ANL · Nasdaq
ANL stood above a rising 150-day average in 37 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 11.3% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Just dropped out
- Weeks in an uptrend
- out for 1
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $659K
- Officials’ trades on record
- 0
- Institutions holding
- 40 (+17)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 37 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Ping JiDirector | sold | 5,000at $16.03 | 30 Sep 2026filed 1 Oct 2026 |
| Ping JiDirector | sold | 5,000at $15.95 | 30 Sep 2026filed 1 Oct 2026 |
| Ping JiDirector | sold | 214at $15.77 | 29 Sep 2026filed 1 Oct 2026 |
| Ping JiDirector | sold | 5,000at $16.63 | 22 Sep 2026filed 24 Sep 2026 |
| Xiaofeng YeCFO | sold | 5,667at $14.25 | 26 Aug 2026filed 26 Aug 2026 |
| Xiaofeng YeCFO | sold | 6,000at $13.98 | 24 Aug 2026filed 26 Aug 2026 |
| Yang LuCEO | sold | 10at $13.18 | 13 May 2026filed 21 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Cormorant Asset Management, LPadded · filed 14 Aug 2026 | 3,978,229$45.7M | +1,080,372+37.3% |
| Venrock Adviser, LLCunchanged · filed 14 Aug 2026 | 3,212,731$36.9M | 00.0% |
| Balyasny Asset Management L.P.added · filed 14 Aug 2026 | 3,061,668$35.2M | +2,183,822+248.8% |
| Point72 Asset Management, L.P.new · filed 14 Aug 2026 | 2,140,664$24.6M | +2,140,664 |
| MPM BIOIMPACT LLCnew · filed 14 Aug 2026 | 1,936,291$22.3M | +1,936,291 |
| PERCEPTIVE ADVISORS LLCnew · filed 14 Aug 2026 | 1,793,190$20.6M | +1,793,190 |
| Casdin Capital, LLCadded · filed 14 Aug 2026 | 1,250,000$14.4M | +711,539+132.1% |
| ADAR1 Capital Management, LLCadded · filed 14 Aug 2026 | 1,017,805$11.7M | +899,896+763.2% |
| Octagon Capital Advisors LPnew · filed 14 Aug 2026 | 934,716$10.7M | +934,716 |
| MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026 | 807,832$9.3M | +126,057+18.5% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
No ratio computed from its SEC filings yet.
Analyst forecasts
No analyst forecasts yet.